Glenmark’s Ryaltris Close To Entry In Major Eastern Europe Market

Indian Firm Has Launched Already In Ukraine, Australia And South Africa

Having divested a basket of allergy treatments in Russia and the CIS to Dr Reddy’s last year, Glenmark is gearing up to launch its novel Ryaltris nasal spray in a major Eastern Europe market.

Russia_Night
Ryaltris is under review with the US FDA, as well as regulators across Europe, Canada and Brazil. • Source: Shutterstock

More from Products

More from Generics Bulletin